Compare iShares MSCI Canada (TSX) (EWC) vs Moderna, Inc. (MRNA) Price & Performance

iShares MSCI Canada (TSX)Trade

Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

iShares MSCI Canada (TSX) vs Moderna, Inc. — how do they compare? iShares MSCI Canada (TSX) trades at $59.38, while Moderna, Inc. trades at $66.35 (market cap $27.09B). The key difference: iShares MSCI Canada (TSX) is trading nearer its 52-week high, Moderna, Inc. nearer its low. Which is the better fit depends on your goals.

	EWC	MRNA
Sector	Broad Market / Factor	Health
52-Week High	$59.49	$81.80
52-Week Low	$45.86	$22.36
Market Cap	—	$27.09B
Enterprise Value	—	$23.19B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MSCI Canada (TSX)

No Aura AI signal available yet.

Moderna, Inc.

Moderna (MRNA) trades at $67.44, showing modest daily gains amid a bullish technical signal. The company continues to beat earnings expectations despite reporting significant net losses, with revenue declining from pandemic peaks to $1.92B in 2025. Recent positive developments include EU RSV vaccine contracts, Phase 1 cancer trial initiation, and FDA advisory panel support for its mRNA flu vaccine, driving recent stock momentum.

While Moderna's pipeline expansion beyond COVID-19 shows promise with oncology and rare disease applications, substantial financial risks persist with negative profit margins and cash burn. Analyst consensus remains cautious with a $49 price target below current levels, reflecting concerns about revenue sustainability versus pipeline execution risks and valuation metrics.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

EWC

Global markets show mixed 2026 gains; Japan's Nikkei leads with 33.6% rise, India lags down 8.9%.ETF Trends · 2 days agoNeutral View details →

MRNA

Arbutus sues Pfizer/BioNTech over LNP patents, gets $178M from Moderna, plans $230M share buybackGlobeNewsWire · 6 hours agoNeutral Moderna's Q2 report expected uneventful; key focus on COVID vaccine demand and Phase III melanoma data.Proactive Investors · 2 days agoNeutral View details →

About iShares MSCI Canada (TSX)

EWC is a country-specific ETF that tracks the performance of the Canadian equity market. It provides exposure to large and mid-sized companies in Canada, with heavy concentrations in financials and energy, including Royal Bank of Canada, Shopify, and Enbridge.

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.